Diploma Shares Rise After J.P. Morgan Upgrades to Overweight, Lifts Target to 8,250p

Diploma Plc shares climbed around 1.5% to trade near 7,305 pence on Monday after J.P. Morgan upgraded the London-listed technical products distributor from Neutral to Overweight and raised its December 2027 price target to 8,250 pence from a prior December 2026 target of 5,760 pence. The broker also lifted its FY26 and FY27 adjusted EPS estimates by roughly 14.6–14.7%, as reported by Investing.com and EconoTimes.

J.P. Morgan Upgrades Diploma to Overweight, Lifts Target to 8,250p as Shares Rise 1.5%

J.P. Morgan raised its rating on Diploma (LON: DPLM) to Overweight and set a new December 2027 price target of 8,250 pence. The bank increased its FY26 adjusted EPS estimate by 14.6% to 253.98 pence (from 221.68 pence) and its FY27 adjusted EPS forecast by 14.7% to 263.65 pence (from 229.80 pence). Analyst Jane Sparrow and the team said they had “underestimated the earnings upgrade capacity of Diploma in 2026.”

Shares opened at 7,240 pence and reached a session high of 7,310 pence, trading around 7,305 pence for a gain of approximately 1.5%. The stock remains well above its 52-week low of 4,970 pence but below its 52-week high of 7,755 pence. The FTSE 100 was largely flat near 10,812 in early trade.

J.P. Morgan Raises FY26 EPS Estimate 14.6% and Price Target to 8,250p 

The upgrade and substantial earnings estimate increases provided a clear catalyst for the stock-specific outperformance. J.P. Morgan highlighted upside from organic growth, margin expansion and M&A through FY26. The new 8,250 pence target implies further upside from current levels and is based on a 22 times CY2027 EV/EBIT multiple, aligned with peer averages. Investors responded positively to the broker’s acknowledgement of stronger-than-expected earnings momentum after two years of robust growth.

Diploma Delivers 15% Organic Growth, 36% EPS Growth and 300bps Margin Expansion 

Diploma delivered strong first-half results for the six months ended 31 March 2026, with organic revenue growth of 15%, total revenue up 17% to £851.1 million (including 3% from net acquisitions), adjusted operating margin expanding 300 basis points to 24.5%, and adjusted EPS rising 36% to 109.2 pence. The company has upgraded full-year guidance multiple times, most recently pointing to higher organic growth and margins. Consensus FY26 EPS estimates have risen 34% and FY27 estimates 33% since the FY25 results in November 2025, with the share price advancing roughly in line at about 36% over the same period. Diploma trades on the FTSE 100 (having moved up from the FTSE 250) and is viewed as a quality compounder with a disciplined acquisition strategy.

Investors Focus on Organic Growth, M&A Execution and Further Earnings Upgrades 

Investors will watch for further evidence of sustained organic growth and successful integration of recent acquisitions. J.P. Morgan expects organic growth to moderate toward a long-term average of around 6% in FY27 after two strong years, with some margin normalisation. Additional upgrades from other brokers, updates on the M&A pipeline, and the company’s next trading statement or full-year results will be key near-term catalysts. Relative valuation against decentralised compounders and U.S. distributors will also influence sentiment.